Targeting ion channels for the treatment of autoimmune neuroinflammation
Pharmacological targeting of ion channels has long been recognized as an attractive strategy for the treatment of various diseases. Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system with a prominent neurodegenerative component. A multitude of different cell types are in...
Main Authors: | Stefan Bittner, Sven G. Meuth |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-09-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285613487782 |
Similar Items
-
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
by: Tobias Brummer, et al.
Published: (2021-08-01) -
Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation
by: Audrey Ortega-Ramírez, et al.
Published: (2017-01-01) -
Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells
by: Christina B. Schroeter, et al.
Published: (2021-10-01) -
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms
by: Stefan Bittner, et al.
Published: (2015-07-01) -
Neuroinflammation Treatment via Targeted Delivery of Nanoparticles
by: Susana R. Cerqueira, et al.
Published: (2020-09-01)